NV701

pilocarpine · Novus Vision LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NV701, covering 2025-09-05 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of NV701 (Pilocarpine 1.25%) Compared With Vuity (Pilocarpine 1.25%) on Pupil Size in Subjects With Presbyopia [EARLY_Phase 1]

See pricing